Gabriella Macchia

Head of External Beam Radiotherapy Unit

Ottawa Hospital Research Institute

Italy

Research Interests

Explore related searches

Professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Gabriella Macchia is the Head of the External Beam Radiotherapy Unit at Responsible Research Hospital in Italy. Her research areas focus on innovative treatment approaches in oncology, particularly involving radiotherapy for cancer patients. Recent publications include studies on pain management in elderly cancer patients, treatment of oligometastatic lesions, and predictive modeling for acute toxicity during salvage radiotherapy. Dr. Macchia is actively engaged in multicenter trials aiming to enhance therapeutic outcomes in complex oncological cases.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Collaborators (6)

Elisa D'Angelo

University of Bologna

ITALY

View details

Pantaleo GRECO

Full Professore

University of Ferrara

ITALY

View details

Alessio Giuseppe Morganti

ALMA MATER STUDIORUM UNIVERSITY OF BOLOGNA

ITALY

View details

Stefania Rizzo

Università del Salento

SWITZERLAND

View details

Francesco DEODATO

Professore Associato

Università Cattolica del Sacro Cuore

ITALY

View details

Savino Cilla

Head-Chief of Medical Physics Unit

Ottawa Hospital Research Institute

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Gabriella Macchia

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

A Multicenter Machine Learning-Based Predictive Model of Acute Toxicity in Prostate Cancer Patients Undergoing Salvage Radiotherapy (ICAROS Study)

Older Age Does Not Predict Inadequate Pain Management in Cancer Patients: A Multicenter Prospective Analysis from Italian Radiotherapy Departments (ARISE-Study)

The Surgical Imprint: How Operative Trauma May Shape Radiation Tolerance After Prostatectomy.

Accelerated Radiotherapy for Complicated Bone Metastases: SHARON Bone Randomized Phase III Trial Shows Non-Inferiority Compared to Standard Palliative Fractionation (NCT03503682).

Integrating Novel and Classical Prognostic Factors in Locally Advanced Cervical Cancer: A Machine Learning-Based Predictive Model (ESTHER Study).

TREATMENT OF OLIGOMETASTATIC PARENCHYMAL LESIONS IN OVARIAN CANCER WITH STEREOTACTIC ABLATIVE RADIOTHERAPY: A MULTICENTER PROSPECTIVE PHASE II TRIAL (MITO RT3/RAD).

Single-Center Preliminary Experience Treating Endometrial Cancer Patients with Fiducial Markers

In Reply to Gurlek et al

Stereotactic Ablative Radiation Therapy for Oligometastatic Ovarian Cancer Lymph Node Disease: The MITO-RT3/RAD Phase II Trial

Automated single-isocenter stereotactic body radiotherapy for multiple metastases from breast cancer: A case study

Collaborators (6)

Elisa D'Angelo

Pantaleo GRECO

Alessio Giuseppe Morganti

Stefania Rizzo

Francesco DEODATO

Savino Cilla

Make your next move.